SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Manuel Rodríguez-Perálvarez, Tu Vinh Luong, Lorenzo Andreana, Tim Meyer, Amar Paul Dhillon, Andrew Kenneth Burroughs, A Systematic Review of Microvascular Invasion in Hepatocellular Carcinoma: Diagnostic and Prognostic Variability, Annals of Surgical Oncology, 2013, 20, 1, 325

    CrossRef

  2. 2
    Linda L. Wong, Willscott E. Naugler, Jonathan Schwartz, David L. Scott, Renuka Bhattacharya, Jorge Reyes, Susan L. Orloff, Impact of locoregional therapy and alpha-fetoprotein on outcomes in transplantation for liver cancer: a UNOS Region 6 pooled analysis, Clinical Transplantation, 2013, 27, 1
  3. 3
    W.-C. Zhao, L.-F. Fan, N. Yang, H.-B. Zhang, B.-D. Chen, G.-S. Yang, Preoperative predictors of microvascular invasion in multinodular hepatocellular carcinoma, European Journal of Surgical Oncology (EJSO), 2013, 39, 8, 858

    CrossRef

  4. 4
    Roberto Galuppo, Angie McCall, Roberto Gedaly, The Role of Bridging Therapy in Hepatocellular Carcinoma, International Journal of Hepatology, 2013, 2013, 1

    CrossRef

  5. 5
    Yun-Hsuan Lee, Chia-Yang Hsu, Yi-Hsiang Huang, Chien-Wei Su, Han-Chieh Lin, Cheng-Yuan Hsia, Teh-Ia Huo, α-Fetoprotein-to-Total Tumor Volume Ratio Predicts Post-operative Tumor Recurrence in Hepatocellular Carcinoma, Journal of Gastrointestinal Surgery, 2013, 17, 4, 730

    CrossRef

  6. 6
    Laetitia Fartoux, Sona Balogova, Valérie Nataf, Khaldoun Kerrou, Virginie Huchet, Olivier Rosmorduc, Jean-Noël Talbot, A pilot comparison of 18F-fluorodeoxyglucose and 18F-fluorocholine PET/CT to predict early recurrence of unifocal hepatocellular carcinoma after surgical resection, Nuclear Medicine Communications, 2012, 33, 7, 757

    CrossRef

  7. 7
    Quirino Lai, Alfonso W. Avolio, Tommaso M. Manzia, Roberto Sorge, Salvatore Agnes, Giuseppe Tisone, Pasquale B. Berloco, Massimo Rossi, Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation, Clinical Transplantation, 2012, 26, 2
  8. 8
    Carlos Rodríguez de Lope, Silvia Tremosini, Alejandro Forner, María Reig, Jordi Bruix, Management of HCC, Journal of Hepatology, 2012, 56, S75

    CrossRef

  9. 9
    Olaf Neumann, Miriam Kesselmeier, Robert Geffers, Rossella Pellegrino, Bernhard Radlwimmer, Katrin Hoffmann, Volker Ehemann, Peter Schemmer, Peter Schirmacher, Justo Lorenzo Bermejo, Thomas Longerich, Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors, Hepatology, 2012, 56, 5
  10. 10
    Wen-Chao Zhao, Ning Yang, Nan Zhu, Hai-Bin Zhang, Yong Fu, Hua-Bang Zhou, Wen-Ke Cai, Ben-Dong Chen, Guang-Shun Yang, Patients with Multiple Hepatocellular Carcinomas Within the UCSF Criteria Have Outcomes After Curative Resection Similar to Patients Within the BCLC Early-Stage Criteria, World Journal of Surgery, 2012, 36, 8, 1811

    CrossRef

  11. 11
    A. R. Hakeem, R. S. Young, G. Marangoni, J. P. A. Lodge, K. R. Prasad, Systematic review: the prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma, Alimentary Pharmacology & Therapeutics, 2012, 35, 9